Tempest Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $486 | $486 |
Gross Profit | -66 | -67 | -68 | 243 |
EBITDA | -3,445 | -7,757 | -10,631 | -13,517 |
EBIT | -3,511 | -7,824 | -10,699 | -13,566 |
Net Income | -3,511 | -7,870 | -10,860 | -13,813 |
Net Change In Cash | 0 | 0 | 486 | 486 |
Free Cash Flow | -6,779 | -8,431 | -8,036 | -10,152 |
Cash | 7,514 | 14,280 | 21,511 | 30,268 |
Basic Shares | 4,440 | 3,802 | 3,437 | 27,901 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -389 | -381 | -1,814 | -1,270 |
EBITDA | -40,138 | -27,661 | -33,453 | -26,646 |
EBIT | -40,527 | -28,042 | -34,091 | -27,020 |
Net Income | -41,843 | -29,491 | -35,709 | -28,302 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -33,462 | -27,527 | -31,634 | -26,092 |
Cash | 30,268 | 39,230 | 31,230 | 51,829 |
Basic Shares | 27,902 | 15,416 | 888 | 291 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.79 |
2025-06-30 | -$2.07 |
2025-03-31 | -$3.16 |
2024-12-31 | -$0.31 |
